COMP <GO>
XENE vs IRON // EV/EBITDA & P/E VALUATION
Xenon Pharmaceuticals Inc. (NASDAQ) VS. Disc Medicine Inc. (NASDAQ) • 15-METRIC TALLY: XENE 2
— IRON 7
■ METRIC PARITY
LAST: $37.62 (+0.56%) • MKT CAP: $3.62B
valuation
—
LAST: $78.62 (-2.75%) • MKT CAP: $3.59B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XENE VS. IRON)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XENE | IRON | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -27.50% | -7.50 | IRON | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.70% | -4.93% | -2.77 | IRON | /fcf-yield <GO> |
| Operating Margin | -36.70% | -22.90% | -13.80 | IRON | /operating-margins <GO> |
| Net Profit Margin | -34.00% | -20.60% | -13.40 | IRON | /net-margins <GO> |
| Revenue Growth (YoY) | 7.70% | 16.50% | -8.80 | IRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 26.00 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.3 | 62.4 | -18.10 | IRON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.90 | +0.20 | XENE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 20.0x | +9.00 | IRON | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.62B | $3.59B | $34.1M | XENE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XENE REV | IRON REV | XENE GROSS % | IRON GROSS % | XENE FCF | IRON FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $660.9M | — | — | -$279.9M | -$181.3M |
| FY 2024 | $782.0M | $363.2M | — | — | -$184.5M | -$94.4M |
| FY 2023 | $599.4M | $255.2M | — | — | -$151.1M | -$73.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XENE // BETA 1.10
IRON // BETA 0.90